Option Care Health (NASDAQ:OPCH) Sees Unusually-High Trading Volume – Time to Buy?

Option Care Health, Inc. (NASDAQ:OPCH) saw strong trading volume on Thursday. Approximately 4,789,888 shares were traded during trading, an increase of 63% from the average daily volume of 2,933,298 shares. The stock last traded at $31.6850 and had previously closed at $31.29.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on OPCH shares. Citizens Jmp lowered Option Care Health from a “market outperform” rating to a “hold” rating in a report on Wednesday, October 7th. Barrington Research downgraded Option Care Health from an “outperform” rating to a “hold” rating in a research note on Wednesday, October 7th. Truist Financial set a $32.05 target price on Option Care Health in a research report on Wednesday, October 7th. Deutsche Bank Aktiengesellschaft cut shares of Option Care Health from a “buy” rating to a “hold” rating and reduced their target price for the stock from $26.00 to $24.00 in a report on Thursday, July 30th. Finally, UBS Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the company from $39.00 to $32.05 in a report on Friday, October 9th. Two investment analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $29.48.

Option Care Health Stock Performance

The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. The firm’s 50 day moving average is $26.17 and its 200-day moving average is $26.47. The stock has a market capitalization of $4.77 billion, a price-to-earnings ratio of 23.97, a PEG ratio of 1.90 and a beta of 0.58.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The company had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%. Option Care Health’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.41 EPS. Analysts forecast that Option Care Health, Inc. will post 1.70 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. Vise Technologies Inc. grew its stake in Option Care Health by 88.7% in the 3rd quarter. Vise Technologies Inc. now owns 20,516 shares of the company’s stock valued at $461,000 after acquiring an additional 9,646 shares during the period. Choreo LLC purchased a new stake in shares of Option Care Health during the third quarter worth about $419,000. VestGen Advisors LLC purchased a new stake in shares of Option Care Health during the third quarter worth about $220,000. Leeward Investments LLC MA lifted its stake in Option Care Health by 20.1% in the 3rd quarter. Leeward Investments LLC MA now owns 848,059 shares of the company’s stock valued at $19,073,000 after buying an additional 142,007 shares in the last quarter. Finally, Sterling Capital Management LLC boosted its holdings in Option Care Health by 361.7% in the 3rd quarter. Sterling Capital Management LLC now owns 4,866 shares of the company’s stock worth $109,000 after buying an additional 3,812 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.